Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects

Registry ID

EUCTR2015-000284-14

Source registry

EUCTR

Status

GB - no longer in EU/EEA

Phase

PHASE3

Sponsor

University of Calgary

Start date

2016-01-05

Last update

2026-08-16

Conditions

• Vasovagal Syncope

Summary

Will Metoprolol reduces the time to a first recurrence of syncope(fainting) in patients ≥40 years old who have a high likelihood of recurrent vasovagal syncope( fainting).

Locations

• , , UK

Related clinical trials

• Assessment of Stroke Volume and Cardiac Output in Response to Varying Heart Rates
• The Effect of Water Carbonation on Orthostatic Tolerance
• Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry
• Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
• Study of Atomoxetine in the Prevention of Vasovagal Syncope

View on source registry